These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 4459505)
21. Live attenuated varicella vaccine: the KMcC strain in healthy children. Arbeter AM; Starr SE; Weibel RE; Neff BJ; Plotkin SA Pediatrics; 1983 Mar; 71(3):307-12. PubMed ID: 6298698 [TBL] [Abstract][Full Text] [Related]
22. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077 [TBL] [Abstract][Full Text] [Related]
23. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K; Nicoara C; Germann D; Matter L Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837 [TBL] [Abstract][Full Text] [Related]
24. Studies on the live attenuated rubella virus vaccine. Nagashima T Kitasato Arch Exp Med; 1973 Jun; 46(1):41-55. PubMed ID: 4210928 [No Abstract] [Full Text] [Related]
25. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions]. Nakazono N Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839 [TBL] [Abstract][Full Text] [Related]
26. [Experience with vaccination with attenuated rubella vaccine (strain HPV-77 adapted to duck cells, 5th passage)]. Rocchi G; Salvadori A Nuovi Ann Ig Microbiol; 1970; 21(4):336-40. PubMed ID: 5518412 [No Abstract] [Full Text] [Related]
27. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM; Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199 [TBL] [Abstract][Full Text] [Related]
28. [1st French study of anti rubella vaccination with the attenuated Cendehill strain]. Lépine P; Zourbas J; Maurin J; Esmieu F Bull Acad Natl Med; 1969; 153(13):248-57. PubMed ID: 4901672 [No Abstract] [Full Text] [Related]
29. [Distribution of anti-rubella virus antibodies in a female population sample of the community of Perugia and serological results of an anti-rubella vaccination experiment]. Iorio AM; Rivosecchi P; Fanelli M; Pitzurra M Boll Ist Sieroter Milan; 1972; 51(5):405-9. PubMed ID: 4656955 [No Abstract] [Full Text] [Related]
30. [Vaccination against rubella]. Böttiger M Lakartidningen; 1979 Oct; 76(41):3516-8. PubMed ID: 522538 [No Abstract] [Full Text] [Related]
31. [Experience with preventive measles, mumps and rubella vaccination in unified Germany]. Gerike E; Tischer A Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543 [TBL] [Abstract][Full Text] [Related]
32. [Experience in vaccination against rubella with the Cenderhill C-51 living and attenuated strain]. Nodari R; Saccani CF; Marangoni L; Fara GM; Galli MG; Bozzetti A; Tarantino F G Mal Infett Parassit; 1970 Jan; 22(1):105-7. PubMed ID: 5420658 [No Abstract] [Full Text] [Related]
33. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. King SM; Saunders EF; Petric M; Gold R Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367 [TBL] [Abstract][Full Text] [Related]
34. Studies on the live attenuated rubella virus vaccine. II. Research concerning attenuation of "Takahashi strain" isolated in Japan. Owada Y; Yamane Y; Nagashima T; Adachi A; Ikumi H Kitasato Arch Exp Med; 1973 Dec; 46(3-4):93-103. PubMed ID: 4218283 [No Abstract] [Full Text] [Related]
35. [Mumps epidemic in vaccinated children in West Switzerland]. Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835 [TBL] [Abstract][Full Text] [Related]
36. Vaccination of adult women with a Japanese rubella vaccine, QEF-passage Biken vaccine. Nakazono N; Sawada H; Takebayashi T; Nakayama N; Ishii K; Kurosawa K; Miura R Biken J; 1978 Sep; 21(3):111-3. PubMed ID: 749912 [No Abstract] [Full Text] [Related]
37. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination. Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678 [TBL] [Abstract][Full Text] [Related]
38. [Rubella vaccination at the present time]. Angela GC G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):337-50. PubMed ID: 4802318 [No Abstract] [Full Text] [Related]
39. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants. Karron RA; Belshe RB; Wright PF; Thumar B; Burns B; Newman F; Cannon JC; Thompson J; Tsai T; Paschalis M; Wu SL; Mitcho Y; Hackell J; Murphy BR; Tatem JM Pediatr Infect Dis J; 2003 May; 22(5):394-405. PubMed ID: 12792378 [TBL] [Abstract][Full Text] [Related]
40. Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination. Lerman SJ; Bollinger M; Brunken JM Pediatrics; 1981 Jul; 68(1):18-22. PubMed ID: 7017582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]